The project Evaluation of the Metoprolol treatment efficacy in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy will be carried out by a team of scientists under the supervision of Dr. Habil. Joanna Kwiatkowska, the head of the Department of Paediatric Cardiology and Congenital Heart Defects at the Medical University of Gdańsk.

The Medical University of Gdańsk (MUG) is a modern academic centre recognized both in Poland and round the world. The university is characterized by a high research and development potential, which includes in particular: experienced and reputable research teams, a growing number of prestigious international publications and grants, as well as a wide range and quality of research confirmed by high categorization of units. The MUG is also the only medical university selected to the elite group of 10 best Polish universities in the prestigious competition: Excellence Initiative – Research University.

For many years, the University has been consistently implementing the scientific and innovative development strategies, supporting activities aimed at funding scientific research conducted at the MUG and directly supervising them. Moreover, it intensively develops research and development activities in the field of non-commercial clinical trials. Currently, it is one of the largest beneficiaries of Medical Research Agency competitions promoting academic clinical trials.

The project will be carried out based on the infrastructure of the University Clinical Centre (UCC) – one of the largest and most modern hospitals in Poland. The UCC has the appropriate personnel and technical potential, ensuring the access to innovative treatment methods and medical equipment at the highest world level.